Focus on the industry in the global mobile phone giant Nokia's annual NokiaWorld Assembly, the Nokia factory in Europe is an important - but was hit by the Romanian factory takeover.
According to foreign media reports, pcba china drug maker Ranbaxy Laboratories (RanbaxyLabs) and Chinese telecom equipment provider ZTE are competitive acquisition of the plant, to pry open their markets in Europe.
Yesterday (October 26), ZTE executives in a not to be named to the "Daily Economic News (microblogging)," Reporters said ZTE has been open as early as before the determination of the Eastern European markets,pcb assembly and in 2012 before the first half of the assembly line in Romania phone. Currently, ZTE is being actively contributed to the acquisition, hope can use the Nokia factory assembly line set up to expand ZTE smart phone market in Eastern Europe. However, it refused to disclose details of the negotiations and the acquisition of the transaction amount of money involved.
Relevant information, Nokia mobile phone manufacturing plant set up Romania in 2008, for Europe, Middle East and Africa production of mobile phones and mobile phone parts, with a total investment of 1.2 billion euros ($ 174 million).
According to the "Daily Economic News" for ZTE in 2011 an important part of a series of adjustment is through the intelligent terminal to terminal, full-service transformation to further enhance its market share in Europe and optimize product distribution, with a view to enhancing the overall profitability of the business end .
It is reported that resurgence of high-end mobile phones Skate4.3 currently in the United Kingdom, France, Spain, the first listing, but did not introduce the country.
According to ZTE sources, its products mainly for 2G and 3G entry-terminal domain. In 2012, ZTE's end-Romanian plant will produce 350,000 to 50 million units, focusing on production Skate4.3 and Blade2 mobile phones, pcba manufacturer also want to use this factory to produce TV products.
At the same time, Nokia refused to comment on the acquisition.